CM Life Sciences II (CMIIU) to Combine with SomaLogic in $1.23Bn Deal

CM Life Sciences II (CMIIU) to Combine with SomaLogic in $1.23Bn Deal

CM Life Sciences II (NASDAQ:CMIIU) announced this morning that it will combine with proteomics firm SomaLogic at an enterprise value of $1.23 billion, or 14.6x its 2022E revenue. SomaLogic provides a technology platform for use both in proteomics research and medical diagnostics. The deal is expected to close in the third quarter, with SomaLogic trading
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.